+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Endocrine Testing Market - Global Forecast 2026-2032- Product Image
Endocrine Testing Market - Global Forecast 2026-2032- Product Image
Sale

Endocrine Testing Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887503
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Endocrine Testing Market is projected to reach USD 16.02 Billion in 2026. It is expected to continue growing at a CAGR of 7.55%, reaching USD 24.87 Billion by 2032.

Endocrine Testing: Executive Overview

Endocrine testing supports the assessment of hormone production, regulation, and related disorders across laboratory, clinical, and public-health settings. Core applications include thyroid, adrenal, pituitary, reproductive, metabolic, and bone-related evaluations. Demand is shaped by chronic disease prevalence, ageing populations, preventive care, clinical guidelines, laboratory capacity, and the increasing use of decentralized testing.

How Endocrine Testing Is Evolving Across Care Pathways

The landscape is shifting from episodic testing toward more coordinated diagnostic pathways. Laboratories and clinicians increasingly emphasize appropriate test selection, repeat testing only when clinically justified, standardized reference intervals, faster turnaround, and integration of results with patient history and other biomarkers. Home collection, point-of-care workflows, automated platforms, and electronic ordering are also changing how endocrine assessments are accessed and managed, while quality assurance and interpretation remain essential.

Artificial Intelligence Is Strengthening Interpretation and Operations

Artificial intelligence is being applied to laboratory workflow management, abnormal-result prioritization, image and signal interpretation, clinical decision support, and identification of testing patterns that may warrant follow-up. In endocrine testing, its value depends on high-quality longitudinal data, harmonized assays, transparent validation, and human oversight because hormone concentrations vary with age, sex, pregnancy, medication use, timing, and physiological state. Leaders should treat AI as an augmentative capability and maintain governance for bias, privacy, explainability, and clinical accountability.

Regional Insights: Uneven Access Meets Expanding Diagnostic Needs

North America combines advanced laboratory infrastructure with strong emphasis on utilization management, interoperability, and chronic disease monitoring. Europe is influenced by coordinated health systems, regulatory requirements, and efforts to harmonize laboratory quality across countries. Asia-Pacific presents significant variation in access, with sophisticated capabilities in some urban centers alongside capacity-building needs elsewhere. Latin America is characterized by expanding private and public diagnostic networks but uneven availability and affordability. The Middle East is investing in specialized healthcare infrastructure and centralized laboratory services, while Africa continues to face gaps in equipment, trained personnel, referral pathways, and continuity of care. Across all regions, reliable supply chains, workforce development, and locally appropriate reference intervals are important priorities.

Group Insights: Policy Blocs Shape Standards and Access

ASEAN members are balancing cross-border diversity in healthcare infrastructure with efforts to improve laboratory connectivity and diagnostic access. BRICS countries reflect varied disease burdens, regulatory environments, and laboratory capabilities, creating opportunities for shared learning while requiring locally validated approaches. The European Union places strong emphasis on quality systems, data governance, and alignment of diagnostic practices across member states. G7 systems generally have mature laboratory networks and are focused on value-based utilization, interoperability, and workforce resilience. GCC countries are strengthening specialized and centralized healthcare capacity, with attention to localization and referral efficiency. NATO members span diverse health systems, making preparedness, supply continuity, and interoperable clinical information important considerations.

Country Insights: Distinct Priorities Across Major Health Systems

Australia emphasizes coordinated primary care, laboratory quality, and access across geographically dispersed communities. Brazil is addressing regional disparities while expanding diagnostic capacity through public and private networks. Canada focuses on equitable access, provincial coordination, and appropriate utilization. China is developing sophisticated urban capabilities alongside broader service expansion and standardization. France, Germany, Italy, and Spain are shaped by established public health systems, regulatory oversight, and efforts to manage laboratory efficiency and workforce pressures. India is combining large-scale diagnostic expansion with substantial variation between urban and rural settings. Japan and South Korea emphasize ageing-related care, technology adoption, and highly organized healthcare delivery. Mexico is working to improve access, referral systems, and quality consistency. Russia faces the need to sustain laboratory capacity, supply continuity, and standardized clinical pathways. The United Kingdom prioritizes integrated care, operational productivity, and consistent diagnostic services. The United States emphasizes guideline-based utilization, interoperability, innovation, and management of fragmented care pathways.

Five Priorities for Leaders in Endocrine Diagnostics

Industry leaders should first strengthen analytical quality through calibration, proficiency testing, validated reference intervals, and clear preanalytical requirements. Second, they should design integrated pathways that connect primary care, specialist review, laboratory services, and follow-up. Third, investment in interoperable data systems can reduce duplication and improve longitudinal interpretation. Fourth, decentralized and home-based options should be expanded only where specimen stability, patient selection, connectivity, and confirmatory pathways are demonstrably reliable. Finally, organizations should establish responsible AI governance, develop specialized workforce capabilities, monitor access disparities, and align innovation with evidence-based clinical value.

Research Methodology: Structured Analysis of Endocrine Testing Dynamics

This executive summary uses a qualitative, evidence-oriented framework centered on the clinical role of endocrine testing, diagnostic workflow evolution, technology adoption, regional health-system conditions, and policy-group characteristics. Analysis should be validated against peer-reviewed literature, clinical guidelines, government health statistics, regulatory publications, laboratory quality standards, and primary healthcare-system documentation. Comparisons require attention to differences in terminology, assay methods, reference intervals, reimbursement, reporting practices, population structure, and access. No market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Build Trustworthy, Connected Endocrine Testing Systems

Endocrine testing is becoming more integrated, data-enabled, and distributed across care settings. The strongest long-term outcomes will depend less on technology alone than on analytical standardization, appropriate interpretation, equitable access, reliable referral pathways, and accountable use of artificial intelligence. Organizations that combine clinical rigor with interoperable infrastructure and workforce development will be better positioned to improve diagnostic quality and patient management across diverse health systems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Endocrine Testing Market, by Type
7.1. Introduction
7.2. Cortisol Test
7.3. Dehydroepiandrosterone Sulfate (DHEAS) Test
7.4. Estradiol (E2) Test
7.5. Human Chorionic Gonadotropin (hCG) Hormone Test
7.6. Insulin Test
7.7. Sex Hormone Tests
7.8. Thyroid Stimulating Hormone (TSH) Test
8. Endocrine Testing Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Chromatography Systems
8.2.2. Immunoassay Analyzers
8.2.3. Mass Spectrometry Systems
8.3. Reagents & Kits
8.3.1. Calibrators
8.3.2. Control Materials
8.3.3. Diagnostic Kits
8.4. Software And Services
8.4.1. Informatics Solutions
8.4.2. Maintenance Services
9. Endocrine Testing Market, by Sample Type
9.1. Introduction
9.2. Blood
9.3. Saliva
9.4. Urine
10. Endocrine Testing Market, by Technology
10.1. Introduction
10.2. Clinical Chemistry
10.3. Immunoassay
10.4. Monoclonal & Polyclonal Antibody Technologies
10.5. Sensor Technology
10.6. Tandem Mass Spectrometry
11. Endocrine Testing Market, by Disease Type
11.1. Introduction
11.2. Adrenal Disorders
11.2.1. Addison's Disease
11.2.2. Cushing's Syndrome
11.3. Diabetes
11.4. Gonadal Disorders
11.4.1. Hypogonadism
11.4.2. Polycystic Ovary Syndrome
11.5. Thyroid Dysfunction
11.5.1. Hyperthyroidism
11.5.2. Hypothyroidism
12. Endocrine Testing Market, by End User
12.1. Introduction
12.2. Academic Institutions
12.3. Diagnostic Laboratories
12.4. Hospitals & Clinics
12.5. Research Institutes
13. Endocrine Testing Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. Europe
13.4. North America
13.5. Latin America
13.6. Africa
13.7. Middle East
14. Endocrine Testing Market, by Group
14.1. Introduction
14.2. NATO
14.3. G7
14.4. European Union
14.5. BRICS
14.6. ASEAN
14.7. GCC
15. Endocrine Testing Market, by Country
15.1. Introduction
15.2. United States
15.3. China
15.4. Germany
15.5. Japan
15.6. India
15.7. United Kingdom
15.8. France
15.9. Canada
15.10. Italy
15.11. Australia
15.12. South Korea
15.13. Brazil
15.14. Mexico
15.15. Russia
15.16. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. ACON Laboratories, Inc.
17.3. Agilent Technologies, Inc.
17.4. BioCheck Inc.
17.5. Biogenix Inc. Pvt. Ltd.
17.6. Blueprint Genetics Oy
17.7. Creative Diagnostics
17.8. Danaher Corporation
17.9. DiaSorin S.p.A.
17.10. Eagle Biosciences
17.11. Eurofins SE
17.12. F. Hoffmann-La Roche Ltd.
17.13. Getein Biotech, Inc.
17.14. Laboratory Corporation of America Holdings
17.15. Quest Diagnostics Incorporated
17.16. Randox Laboratories Ltd.
17.17. Shenzhen New Industries Biomedical Engineering Co., Ltd.
17.18. Siemens Healthcare GmbH
17.19. Thermo Fisher Scientific Inc.
17.20. Trivitron Healthcare
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Endocrine Testing Market, Years Considered for the Study
FIGURE 2. Global Endocrine Testing Market, Research Design
FIGURE 3. Global Endocrine Testing Market, Research Framework
FIGURE 4. Global Endocrine Testing Market, Data Triangulation
FIGURE 5. Global Endocrine Testing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Endocrine Testing Market Size, by Type, 2025 vs 2032 (%)
FIGURE 7. Global Endocrine Testing Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Endocrine Testing Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Endocrine Testing Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Endocrine Testing Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Endocrine Testing Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Endocrine Testing Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 13. Global Endocrine Testing Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Endocrine Testing Market Size, by Disease Type, 2025 vs 2032 (%)
FIGURE 15. Global Endocrine Testing Market Size, by Disease Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Endocrine Testing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Endocrine Testing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Endocrine Testing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Endocrine Testing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Endocrine Testing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Endocrine Testing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Endocrine Testing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Endocrine Testing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Endocrine Testing Market Segmentation & Coverage
TABLE 2. Global Endocrine Testing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 4. Global Cortisol Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cortisol Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cortisol Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Dehydroepiandrosterone Sulfate (DHEAS) Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Dehydroepiandrosterone Sulfate (DHEAS) Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Dehydroepiandrosterone Sulfate (DHEAS) Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Estradiol (E2) Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Estradiol (E2) Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Estradiol (E2) Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Human Chorionic Gonadotropin (hCG) Hormone Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Human Chorionic Gonadotropin (hCG) Hormone Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Human Chorionic Gonadotropin (hCG) Hormone Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Insulin Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Insulin Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Insulin Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Sex Hormone Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Sex Hormone Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Sex Hormone Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Thyroid Stimulating Hormone (TSH) Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Thyroid Stimulating Hormone (TSH) Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Thyroid Stimulating Hormone (TSH) Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 26. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Chromatography Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Chromatography Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Chromatography Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Immunoassay Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Immunoassay Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Immunoassay Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Mass Spectrometry Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Mass Spectrometry Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Mass Spectrometry Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Reagents & Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Reagents & Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Reagents & Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Calibrators Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Calibrators Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Calibrators Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Control Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Control Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Control Materials Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Diagnostic Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Diagnostic Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Diagnostic Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Software And Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Software And Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Software And Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Informatics Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Informatics Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Informatics Solutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Maintenance Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Maintenance Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Maintenance Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 60. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 70. Global Clinical Chemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Clinical Chemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Clinical Chemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Monoclonal & Polyclonal Antibody Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Monoclonal & Polyclonal Antibody Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Monoclonal & Polyclonal Antibody Technologies Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Sensor Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Sensor Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Sensor Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Tandem Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Tandem Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Tandem Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 86. Global Adrenal Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Adrenal Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Adrenal Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Addison's Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Addison's Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Addison's Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Cushing's Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Cushing's Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Cushing's Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Gonadal Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Gonadal Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Gonadal Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Hypogonadism Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Hypogonadism Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Hypogonadism Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Polycystic Ovary Syndrome Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Polycystic Ovary Syndrome Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Polycystic Ovary Syndrome Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Thyroid Dysfunction Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Thyroid Dysfunction Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Thyroid Dysfunction Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Hyperthyroidism Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Hyperthyroidism Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Hyperthyroidism Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Hypothyroidism Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Hypothyroidism Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Hypothyroidism Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. Global Academic Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Academic Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Academic Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Endocrine Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Endocrine Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. Europe Endocrine Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Europe Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 145. Europe Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 146. Europe Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 147. Europe Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 148. Europe Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 149. Europe Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 150. Europe Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 151. Europe Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 152. Europe Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 153. Europe Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 154. Europe Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 155. Europe Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. North America Endocrine Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. North America Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 158. North America Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 159. North America Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 160. North America Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 161. North America Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 162. North America Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 163. North America Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 164. North America Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 165. North America Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 166. North America Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 167. North America Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 168. North America Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Latin America Endocrine Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 170. Latin America Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 171. Latin America Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 172. Latin America Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 173. Latin America Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 174. Latin America Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 175. Latin America Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 176. Latin America Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 177. Latin America Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 178. Latin America Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 179. Latin America Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 180. Latin America Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 181. Latin America Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Africa Endocrine Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 183. Africa Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 184. Africa Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 185. Africa Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 186. Africa Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 187. Africa Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 188. Africa Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 189. Africa Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 190. Africa Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 191. Africa Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 192. Africa Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 193. Africa Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 194. Africa Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. Middle East Endocrine Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. Middle East Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 197. Middle East Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. Middle East Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 199. Middle East Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 200. Middle East Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 201. Middle East Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 202. Middle East Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 203. Middle East Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 204. Middle East Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 205. Middle East Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 206. Middle East Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 207. Middle East Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. Global Endocrine Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 209. NATO Endocrine Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 210. NATO Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 211. NATO Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. NATO Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 213. NATO Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 214. NATO Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 215. NATO Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 216. NATO Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 217. NATO Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 218. NATO Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 219. NATO Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 220. NATO Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 221. NATO Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. G7 Endocrine Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 223. G7 Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 224. G7 Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 225. G7 Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 226. G7 Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 227. G7 Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 228. G7 Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 229. G7 Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 230. G7 Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 231. G7 Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 232. G7 Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 233. G7 Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 234. G7 Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. European Union Endocrine Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 236. European Union Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 237. European Union Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. European Union Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 239. European Union Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 240. European Union Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 241. European Union Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 242. European Union Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 243. European Union Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 244. European Union Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 245. European Union Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 246. European Union Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 247. European Union Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. BRICS Endocrine Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 249. BRICS Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 250. BRICS Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 251. BRICS Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 252. BRICS Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 253. BRICS Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 254. BRICS Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 255. BRICS Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 256. BRICS Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 257. BRICS Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 258. BRICS Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 259. BRICS Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 260. BRICS Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. ASEAN Endocrine Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 262. ASEAN Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 263. ASEAN Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 264. ASEAN Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 265. ASEAN Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 266. ASEAN Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 267. ASEAN Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 268. ASEAN Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 269. ASEAN Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 270. ASEAN Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 271. ASEAN Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 272. ASEAN Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 273. ASEAN Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. GCC Endocrine Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 275. GCC Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 276. GCC Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 277. GCC Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 278. GCC Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 279. GCC Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 280. GCC Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 281. GCC Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 282. GCC Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 283. GCC Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 284. GCC Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 285. GCC Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 286. GCC Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. Global Endocrine Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 288. United States Endocrine Testing Market Size, 2017-2032 (USD Million)
TABLE 289. United States Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 290. United States Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 291. United States Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 292. United States Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 293. United States Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 294. United States Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 295. United States Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 296. United States Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 297. United States Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 298. United States Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 299. United States Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 300. United States Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. China Endocrine Testing Market Size, 2017-2032 (USD Million)
TABLE 302. China Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 303. China Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 304. China Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 305. China Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 306. China Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 307. China Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 308. China Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 309. China Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 310. China Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 311. China Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 312. China Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 313. China Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 314. Germany Endocrine Testing Market Size, 2017-2032 (USD Million)
TABLE 315. Germany Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 316. Germany Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 317. Germany Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 318. Germany Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 319. Germany Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 320. Germany Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 321. Germany Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 322. Germany Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 323. Germany Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 324. Germany Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 325. Germany Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 326. Germany Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 327. Japan Endocrine Testing Market Size, 2017-2032 (USD Million)
TABLE 328. Japan Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 329. Japan Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 330. Japan Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 331. Japan Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 332. Japan Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 333. Japan Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 334. Japan Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 335. Japan Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 336. Japan Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 337. Japan Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 338. Japan Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 339. Japan Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 340. India Endocrine Testing Market Size, 2017-2032 (USD Million)
TABLE 341. India Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 342. India Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 343. India Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 344. India Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 345. India Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 346. India Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 347. India Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 348. India Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 349. India Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 350. India Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 351. India Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 352. India Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 353. United Kingdom Endocrine Testing Market Size, 2017-2032 (USD Million)
TABLE 354. United Kingdom Endocrine Testing Market Size, by Type, 2017-2032 (USD Million)
TABLE 355. United Kingdom Endocrine Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 356. United Kingdom Endocrine Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 357. United Kingdom Endocrine Testing Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 358. United Kingdom Endocrine Testing Market Size, by Software And Services, 2017-2032 (USD Million)
TABLE 359. United Kingdom Endocrine Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 360. United Kingdom Endocrine Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 361. United Kingdom Endocrine Testing Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 362. United Kingdom Endocrine Testing Market Size, by Adrenal Disorders, 2017-2032 (USD Million)
TABLE 363. United Kingdom Endocrine Testing Market Size, by Gonadal Disorders, 2017-2032 (USD Million)
TABLE 364. United Kingdom Endocrine Testing Market Size, by Thyroid Dysfunction, 2017-2032 (USD Million)
TABLE 365. United Kingdom Endocrine Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 366. France Endocrine Testing Market Size, 2017-2032

Companies Mentioned

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Agilent Technologies, Inc.
  • BioCheck Inc.
  • Biogenix Inc. Pvt. Ltd.
  • Blueprint Genetics Oy
  • Creative Diagnostics
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eagle Biosciences
  • Eurofins SE
  • F. Hoffmann-La Roche Ltd.
  • Getein Biotech, Inc.
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare

Related Topics

Related Reports

Endocrine Testing - Global Strategic Business Report - Product Image

Endocrine Testing - Global Strategic Business Report

  • Report
  • 379 Pages
  • Global
From
Endocrine Testing Market Size, Share & Trends Analysis Report by Test Type, Technology, End-use, Region, and Segment Forecasts, 2026-2033 - Product Image

Endocrine Testing Market Size, Share & Trends Analysis Report by Test Type, Technology, End-use, Region, and Segment Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Endocrine Testing Market Report by Test Type, Technology, End Use, and Region 2026-2034 - Product Image

Endocrine Testing Market Report by Test Type, Technology, End Use, and Region 2026-2034

  • Report
  • 150 Pages
  • Global
From
Endocrine Testing Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030 - Product Image

Endocrine Testing Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • Report
  • 185 Pages
  • Global
From
Endocrine Testing Market Outlook 2026-2034: Market Share, and Growth Analysis by Test Type, End User, Technology, Application - Product Image

Endocrine Testing Market Outlook 2026-2034: Market Share, and Growth Analysis by Test Type, End User, Technology, Application

  • Report
  • 160 Pages
  • Global
From

About the Endocrine Testing Market

The Endocrine Testing market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. It is used to diagnose and monitor endocrine disorders, such as diabetes, thyroid disorders, and adrenal disorders. Endocrine testing is used to measure the levels of hormones in the body, such as insulin, cortisol, and testosterone. It is also used to diagnose and monitor diseases such as Cushing's syndrome, Addison's disease, and hyperthyroidism. Endocrine testing is used to diagnose and monitor a variety of conditions, including infertility, obesity, and metabolic disorders. Endocrine testing is a critical component of IVD, as it helps to diagnose and monitor endocrine disorders. Endocrine testing is used in both clinical and research settings, and is used to diagnose and monitor a variety of conditions. Some companies in the Endocrine Testing market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Thermo Fisher Scientific, and Bio-Rad Laboratories. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.